Literature DB >> 3064937

[Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon].

M A Paix1, J D Poveda, D Malvy, C Bailly, M Merlin, H J Fleury.   

Abstract

A sero-epidemiological study of Hemorrhagic Fever Viruses in a urban population of Cameroon. The authors report the results of a sero-epidemiological survey undertaken in a urban population of Cameroon and concerning Congo, Rift (RVF), Lassa, Ebola, Marburg and Yellow Fever Viruses. On 375 human sera tested, 1.06% show antibodies against RVF virus and 1.87% are positive for anti-Ebola antibodies thus yielding evidence that these two viruses are present in this area of Cameroon. 33.75% have antibodies against Yellow Fever Virus as determined with an Hemagglutination-inhibition test. This quite high percentage, in spite of the weak specificity of the method for this virus, could raise the problem of the opportunity of a vaccination campaign. No antibody to Marburg, Lassa or Congo viruses is detected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064937

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


  8 in total

1.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

Review 2.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.

Authors:  Luke Nyakarahuka; Clovice Kankya; Randi Krontveit; Benjamin Mayer; Frank N Mwiine; Julius Lutwama; Eystein Skjerve
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

Review 3.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection.

Authors:  Hilary Bower; Judith R Glynn
Journal:  Sci Data       Date:  2017-01-31       Impact factor: 6.444

4.  Serological evidence of rift valley fever Phlebovirus and Crimean-Congo hemorrhagic fever orthonairovirus infections among pygmies in the east region of Cameroon.

Authors:  Serge Alain Sadeuh-Mba; Gide Martial Yonga Wansi; Maurice Demanou; Antoine Gessain; Richard Njouom
Journal:  Virol J       Date:  2018-04-06       Impact factor: 4.099

5.  A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.

Authors:  Luke Nyakarahuka; Ilana J Schafer; Stephen Balinandi; Sophia Mulei; Alex Tumusiime; Jackson Kyondo; Barbara Knust; Julius Lutwama; Pierre Rollin; Stuart Nichol; Trevor Shoemaker
Journal:  BMC Infect Dis       Date:  2020-07-01       Impact factor: 3.090

6.  Assessing the determinants of Ebola virus disease transmission in Baka Community of the Tropical Rainforest of Cameroon.

Authors:  Frankline Sevidzem Wirsiy; Alphonse Um Boock; Jane-Francis Tatah Kihla Akoachere
Journal:  BMC Infect Dis       Date:  2021-04-07       Impact factor: 3.090

7.  Seroprevalence of Rift Valley fever virus in domestic ruminants of various origins in two markets of Yaoundé, Cameroon.

Authors:  Francine Yousseu Sado; Huguette Simo Tchetgna; Basile Kamgang; Doumani Djonabaye; Emmanuel Nakouné; Philip J McCall; Roland Ndip Ndip; Charles S Wondji
Journal:  PLoS Negl Trop Dis       Date:  2022-08-11

8.  Seroprevalence and Associated Risk Factors of Rift Valley Fever in Domestic Small Ruminants in the North Region of Cameroon.

Authors:  R Poueme; F Stoek; N Nloga; J Awah-Ndukum; M Rissmann; A Schulz; A Wade; J Kouamo; M Moctar; A Eisenbarth; L God-Yang; S Dickmu; M Eiden; M H Groschup
Journal:  Vet Med Int       Date:  2019-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.